{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-001573","form_type":"8-K","ticker":"BPTH","cik":"0001133818","company_name":"BIO-PATH HOLDINGS, INC.","filed_at":"2024-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.487293+00:00","generated_at":"2026-06-05T16:42:13.098659+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bio-Path Holdings announces 1-for-20 reverse stock split effective Feb 22, 2024","bullets":["Reverse split ratio 1-for-20 effective 5:30 p.m. ET Feb 22, 2024; trading starts split-adjusted on Nasdaq under BPTH on Feb 23.","Shares outstanding reduced from ~12.35M to ~617,833; no fractional shares issued.","New CUSIP number 09057N409; par value unchanged; all options/warrants adjusted.","Company uses DNAbilize antisense RNAi nanoparticle tech for cancer drugs."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-001573","json":"https://secwatch.observer/filing/0001558370-24-001573.json","markdown":"https://secwatch.observer/filing/0001558370-24-001573.md","text":"https://secwatch.observer/filing/0001558370-24-001573.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133818/000155837024001573/0001558370-24-001573-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133818/000155837024001573/bpth-20240221x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T16:42:13.098659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91f91c088a253832996dd874b26656e922a06e07","claim":"BIO-PATH HOLDINGS, INC.: Filed Certificate of Amendment to effect a one-for-twenty reverse stock split of Common Stock (effective 2024-02-22).","evidence_excerpt":"On February 22, 2024, Bio-Path Holdings, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to the Company’s Certificate of Incorporation with the Delaware Secretary of State to effect a reverse stock split of the Company’s Common Stock, par value $0.001 (the “Common Stock”) at a ratio of one-for-twenty, effective at 5:30 p.m. Eastern Time on February 22, 2024 (the “Reverse Stock Split”) .","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1133818/000155837024001573/0001558370-24-001573-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-02-22"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}